tradingkey.logo

Ardelyx rises after new CFO appointment

ReutersOct 13, 2025 5:08 PM

** Shares of biopharmaceutical company Ardelyx ARDX.O up 1.93% to $5.03

** Co appoints Sue Hohenleitner as chief financial officer, effective November 4

** Hohenleitner most recently served as the vice president and CFO of Johnson & Johnson Innovative Medicine North America

** Justin Renz, the current CFO, will continue in his role through co's Q3 10-Q filing

** YTD, the stock has fallen ~1%, including session's moves

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI